Skip to main content
Insulet10-Q: Bookings decline

Insulet reports 63.8% decline in Drug Delivery revenue for six months ended June 30, 2026

Source: Autobound Signal API · 102 signals tracked for Insulet · updated

Get Insulet's live signals in Claude or ChatGPT, or by API

AskWhat changed at Insulet this week? Use Autobound signals for insulet.com.

What happened

Drug Delivery revenue decreased by $16.0 million to $9.1 million from $25.1 million for the six months ended June 30, 2026, driven by lower order volumes from Amgen for the Neulasta Onpro kit.

Source

SEC EDGARAug 5, 2026

Quarterly report (Form 10-Q)

Insulet 10-Q for Quarter ended Jun 30, 2026

Filing excerpt

Drug Delivery revenue was $5.8 million and $10.2 million for the three months ended June 30, 2026 and 2025, respectively, and $9.1 million and $25.1 million for the six months ended June 30, 2026 and 2025, respectively.

sec.gov/Archives/edgar/data/1145197/000114519726000169/podd-20260630.htmRead the full source

Other signals in this filing (7)

Extracted by Autobound

From the Signal API record
Signal
10-Q: Bookings decline

What this signalsFilings often name leadership changes, deals and spending plans.

Period
Quarter ended Jun 30, 2026
Fiscal year end
06/30
Filed
Aug 5, 2026

More 10-Q signals at other companies

The full record

From the Signal API record

Numbers

Dollar figure
$9.1M (Drug Delivery revenue for the six months ended June 30, 2026)
Percent
-63.8% (Drug Delivery revenue decline for the six months ended June 30, 2026)

Details

CIK
1145197
Accession number
0001145197-26-000169
Timeframe
Current year
Quarter
Q2
Filing year
2026
Period end date
Jun 30, 2026
Why it matters
Sales effectiveness tools
Signal category
Revenue

Extraction

Confidence
High
Relevance
70%
Sentiment
Negative
Detected
Nov 9, 2026
signal_type
sec-10q
signal_subtype
bookingsDecline

Use this data

Get every 10-Q signal for Insulet and the companies you sell to, in the tools you already use.

  1. Ask Claude about it

    Connect Autobound to Claude, Claude Code or Cursor with MCP. Then ask: “What changed at Insulet this week?”

  2. Send it to your own tools

    The Signal API returns 10-Q signals for any list of companies as JSON, for your CRM, warehouse or app.

  3. Try it free

    Sign up and spend your free credits on the companies you sell to.

    Start Free1,000 free credits

The API returns more than this page shows

This page shows a preview. The full sec-10q record in the Signal API and MCP can also have these 8 fields. Some fields are empty for some signals.

Company

  • linkedin_urlValue in the API
  • industriesValue in the API
  • employee_count_lowValue in the API
  • employee_count_highValue in the API
  • revenueValue in the API
  • descriptionValue in the API

Signal

  • signal_nameValue in the API
  • associationValue in the API
Show the full JSONThe record on this page and the API request

GET /v1/signals/b71b5039-e28f-497a-a935-c66609a5d34b returns this record as JSON. POST /v1/companies/enrich returns every signal for insulet.com.

{
  "signal_id": "b71b5039-e28f-497a-a935-c66609a5d34b",
  "signal_type": "sec-10q",
  "signal_subtype": "bookingsDecline",
  "detected_at": "2026-11-09T06:32:59.228+00:00",
  "company": {
    "name": "Insulet",
    "domain": "insulet.com"
  },
  "data": {
    "detail": "Drug Delivery revenue decreased by $16.0 million to $9.1 million from $25.1 million for the six months ended June 30, 2026, driven by lower order volumes from Amgen for the Neulasta Onpro kit. Vendors offering contract manufacturing or alternative drug delivery partnership pipelines may find relevant opportunities.",
    "metrics": {
      "pct": -0.638,
      "timeframe": "current_year",
      "pct_context": "Drug Delivery revenue decline for the six months ended June 30, 2026",
      "dollar_context": "Drug Delivery revenue for the six months ended June 30, 2026",
      "dollar_millions": 9.1
    },
    "quarter": "Q2",
    "summary": "Insulet reports 63.8% decline in Drug Delivery revenue for six months ended June 30, 2026",
    "excerpts": "Drug Delivery revenue was $5.8 million and $10.2 million for the three months ended June 30, 2026 and 2025, respectively, and $9.1 million and $25.1 million for the six months ended June 30, 2026 and 2025, respectively.",
    "relevance": 0.7,
    "sentiment": "negative",
    "confidence": "high",
    "source_url": "https://www.sec.gov/Archives/edgar/data/1145197/000114519726000169/podd-20260630.htm",
    "filing_date": "2026-08-05",
    "filing_year": 2026,
    "fiscal_year": 2026,
    "fiscal_year_end": "06/30",
    "period_end_date": "2026-06-30",
    "sales_relevance": "Sales effectiveness tools",
    "signal_category": "revenue"
  }
}

Long text fields are shortened on this page.

Looking up one signal by its id is free. Enrich costs 2 credits per signal returned; a call with no results is free.